Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Caspofungin Market, by Region, 2020-2030 (USD Million)
1.2.2. Caspofungin Market, by Indication, 2020-2030 (USD Million)
1.2.3. Caspofungin Market, by Distribution Channel, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Caspofungin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Caspofungin Market Dynamics
3.1. Caspofungin Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Global Prevalence of Chronic Disorders like Diabetes and Cancer
3.1.1.2. Rising investment in Healthcare Infrastructure
3.1.1.3. Increasing Government Initiatives and Funding towards preventing infectious diseases
3.1.2. Market Challenges
3.1.2.1. High Cost of Treatment
3.1.3. Market Opportunities
3.1.3.1. Increasing Drug Development and Innovation
3.1.3.2. Increasing awareness about fungal infections among public
Chapter 4. Global Caspofungin Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Caspofungin Market, by Indication
5.1. Market Snapshot
5.2. Global Caspofungin Market by Indication, Performance - Potential Analysis
5.3. Global Caspofungin Market Estimates & Forecasts by Indication 2020-2030 (USD Million)
5.4. Caspofungin Market, Sub Segment Analysis
5.4.1. Candidiasis
5.4.2. Thrush
5.4.3. Other Indications
Chapter 6. Global Caspofungin Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Caspofungin Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Caspofungin Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
6.4. Caspofungin Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
Chapter 7. Global Caspofungin Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Caspofungin Market, Regional Market Snapshot
7.4. North America Caspofungin Market
7.4.1. U.S. Caspofungin Market
7.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Caspofungin Market
7.5. Europe Caspofungin Market Snapshot
7.5.1. U.K. Caspofungin Market
7.5.2. Germany Caspofungin Market
7.5.3. France Caspofungin Market
7.5.4. Spain Caspofungin Market
7.5.5. Italy Caspofungin Market
7.5.6. Rest of Europe Caspofungin Market
7.6. Asia-Pacific Caspofungin Market Snapshot
7.6.1. China Caspofungin Market
7.6.2. India Caspofungin Market
7.6.3. Japan Caspofungin Market
7.6.4. Australia Caspofungin Market
7.6.5. South Korea Caspofungin Market
7.6.6. Rest of Asia Pacific Caspofungin Market
7.7. Latin America Caspofungin Market Snapshot
7.7.1. Brazil Caspofungin Market
7.7.2. Mexico Caspofungin Market
7.8. Middle East & Africa Caspofungin Market
7.8.1. Saudi Arabia Caspofungin Market
7.8.2. South Africa Caspofungin Market
7.8.3. Rest of Middle East & Africa Caspofungin Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Fresenius SE & Co. KGaA (Fresenius Kabi)
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Alvogen Inc.
8.3.3. Juno Pharmaceuticals
8.3.4. Cipla Inc.
8.3.5. Merck & Co., Inc.
8.3.6. Athenex, Inc.
8.3.7. Sanofi S.A.
8.3.8. Stanex Drugs and Private Limited
8.3.9. Gland Pharma Limited
8.3.10. Sun Pharmaceutical Industries Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption